158 related articles for article (PubMed ID: 33482915)
1. SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study.
Liu J; Qiu J; Zhang Z; Zhou L; Li Y; Ding D; Zhang Y; Zou D; Wang D; Zhou Q; Lang T
Cell Biosci; 2021 Jan; 11(1):23. PubMed ID: 33482915
[TBL] [Abstract][Full Text] [Related]
2. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
3. Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.
Bellmunt J
Biomedicines; 2018 Aug; 6(3):. PubMed ID: 30072631
[TBL] [Abstract][Full Text] [Related]
4. WNT2-SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer.
Tan XY; Li YT; Li HH; Ma LX; Zeng CM; Zhang TT; Huang TX; Zhao XD; Fu L
Oncogene; 2023 Oct; 42(41):3062-3074. PubMed ID: 37634009
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression and activity by progestins of a member of the SOX gene family of transcriptional modulators.
Graham JD; Hunt SM; Tran N; Clarke CL
J Mol Endocrinol; 1999 Jun; 22(3):295-304. PubMed ID: 10343288
[TBL] [Abstract][Full Text] [Related]
6. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
7. TAp63α targeting of Lgr5 mediates colorectal cancer stem cell properties and sulforaphane inhibition.
Chen Y; Wang MH; Zhu JY; Xie CF; Li XT; Wu JS; Geng SS; Han HY; Zhong CY
Oncogenesis; 2020 Oct; 9(10):89. PubMed ID: 33040081
[TBL] [Abstract][Full Text] [Related]
8. The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?
Vervoort SJ; van Boxtel R; Coffer PJ
Oncogene; 2013 Jul; 32(29):3397-409. PubMed ID: 23246969
[TBL] [Abstract][Full Text] [Related]
9. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.
Zhao J; Xu J; Zhang R
Oncol Lett; 2018 Aug; 16(2):2693-2700. PubMed ID: 30013665
[TBL] [Abstract][Full Text] [Related]
11. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics.
Han K; Lang T; Zhang Z; Zhang Y; Sun Y; Shen Z; Beuerman RW; Zhou L; Min D
Sci Rep; 2018 Jun; 8(1):8537. PubMed ID: 29867083
[TBL] [Abstract][Full Text] [Related]
12. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
13. Sox4 enhances chondrogenic differentiation and proliferation of human synovium-derived stem cell via activation of long noncoding RNA DANCR.
Zhang L; Chen S; Bao N; Yang C; Ti Y; Zhou L; Zhao J
J Mol Histol; 2015 Dec; 46(6):467-73. PubMed ID: 26514989
[TBL] [Abstract][Full Text] [Related]
14. Sox4 up-regulates Cyr61 expression in colon cancer cells.
Wu G; Zhu YZ; Zhang JC
Cell Physiol Biochem; 2014; 34(2):405-12. PubMed ID: 25059387
[TBL] [Abstract][Full Text] [Related]
15. miRNA-381 regulates renal cancer stem cell properties and sunitinib resistance via targeting SOX4.
Lu XJ; Gao WW; Li JC; Qin SF
Biochem Biophys Rep; 2023 Dec; 36():101566. PubMed ID: 37965067
[TBL] [Abstract][Full Text] [Related]
16. De Novo SOX4 Variants Cause a Neurodevelopmental Disease Associated with Mild Dysmorphism.
Zawerton A; Yao B; Yeager JP; Pippucci T; Haseeb A; Smith JD; Wischmann L; Kühl SJ; Dean JCS; Pilz DT; Holder SE; ; ; McNeill A; Graziano C; Lefebvre V
Am J Hum Genet; 2019 Feb; 104(2):246-259. PubMed ID: 30661772
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
18. SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2.
Sun R; Jiang B; Qi H; Zhang X; Yang J; Duan J; Li Y; Li G
Cell Death Dis; 2015 Nov; 6(11):e1990. PubMed ID: 26583330
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus replication and sex-determining region Y box 4 production are tightly controlled by a novel positive feedback mechanism.
Shang J; Zheng Y; Guo X; Mo J; Xie X; Xiong Y; Liu Y; Wu K; Wu J
Sci Rep; 2015 May; 5():10066. PubMed ID: 25970172
[TBL] [Abstract][Full Text] [Related]
20. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
